$LW Lamb Weston - International Headache is No Easy Solve Summary: Lamb Weston’s second quarter featured a stronger volume performance in North America and EBITDA ahead of our expectations; however, a worsening price/mix drag and significant reduction in International

$PAYX Paychex - Modest Revisions Largely Expected; Bottoming Sentiment/Ests Suggest Risk/Reward Improving

$CCL Carnival Corporation - F4Q25 Review: Bears Will Try To Say Santa’s Sleigh Is More Caribbean Capacity When He Visits; Capital Return Story Now Active Summary: Normally when CCL provides initial full-year guidance it usually disappoints, and a sell-off ensues. However, we got

$CTYK Cytokinetics - Aficamten Approved With A Differentiated REMS/Label; We See A Best-In-Class oHCM Oppty & Remain Bullish On ACACIA (2Q26)

$CAG Conagra Brands - Comparisons Drive 3Q Organic Growth Inflection; FY26 Outlook Reiterated Despite Lowered Ardent Mills' contribution Summary: Conagra reported a $0.02 beat versus our 2Q26 estimate driven by a better than expected margin performance with less than expected

$LUNR Intuitive Machines - President Trump's "We Choose to Go to the Moon" Version 2.0 Summary: On December 18th, President Donald Trump unveiled an assertive new US space strategy via his Executive Order, “Ensuring American Space Superiority.” Not since Cold War era, have we

$HEI HEICO - Organic Growth Accelerates in FQ4 Summary: Record Revenue, Earnings, and Cashflow in FQ4. The multi-decade consistency of HEI’s results often dulls the reaction to HEI’s earnings reports but make no mistake, this was an impressive final quarter to a strong year. The

$RKLB Rocket Lab - Awarded $805M Contract with the SDA; Further Cements Co’s Transition from Small Launch Provider to Major Defense Prime Summary: Earlier today, we learned that Rocket Lab has received a contract from the SDA to build 18 satellites for the T3TRK. The award is a

$CAG Conagra Brands - 2Q26 EPS Overview – In Line 2Q, FY26 Reiterated Including Inflection to Organic Sales Growth in 2H

$LW Lamb Weston - 2Q26 Overview – Beat and Sequential Volume Progress; Reiteration of FY26 Guidance Falls Short of Expectations Summary: Lamb Weston reported 2Q26 EBITDA of $285.7 million, down 3%, $16.5 million ahead of our estimate. Sales were flat on a constant currency basis

$BMRN BioMarin Pharmaceuticals - Amicus Deal is Very Logical For BMRN--Company Changing But Is It Stock Changing? Time Will Tell Summary: BMRN announced they're acquiring FOLD for $14.50/sh in an all-cash transaction totaling $4.8B (33% premium) using a $3.7B convertible debt

$CCL Carnival Corporation - F4Q25 First Take: Initial '26 Guidance Better Than Feared; Dividend/Corporate Structure Simplification Are Positive Surprises Summary: F4Q25 Financial Review: Gross/net revenue was $6.33B/$4.94B, essentially in line with our forecast of $6.36B/$4.88B

$NKE Nike - F2Q Reported Topline in Positive Territory but Weaker Outlook Highlights Non-Linear Turnaround; TP to $65 Summary: The pace of recovery remains uneven with F2Q upside and positive reported revenue growth coupled with a F3Q guidance miss and -LSD% topline outlook.

$FDX FedEx - Purple Mitosis: F2Q26 EPS Beat Lays Another Solid Stepping Stone On Path to LTL Spin Summary: FedEx reported F2Q26 adjusted EPS of $4.82, comfortably exceeding our $4.10 estimate and Street consensus of $4.12. Consolidated revenue for the quarter was $23.5bn,

$CTAS Cintas - Post Call Thoughts: Another Quarter of Solid Performance Despite Macro Choppiness Summary: The company reported another beat-and-raise quarter characterized by healthy broad-based growth, continued record retention levels, and no notable changes in customer

$FDS FactSet - Final Thoughts: Improving End-Markets and Better FDS Traction Driving Growth; Tough to Shake the AI Narrative, Though Summary: From a demand perspective, it seems that the end-markets are improving, which we believe is consistent with the commentary we are hearing

$BIRK Birkenstock - Share Gains On Track but Supply Bottlenecks Temper FY26 Guide; TP to $58 Summary: Reaffirmed pathway to +MT% topline growth over the next 3-5 years indicates strong casual footwear share gains, though FY26E guidance for +13-15% cc revenue growth missed

$DRI Darden Restaurants - Investors Shouldn't Be Alfredo A Little Inflation Summary: Darden reported F2Q26 adjusted EPS of $2.08, falling just short of the Street’s $2.10 estimate, primarily due to restaurant margin compression from elevated beef costs. While cyclical commodity

$SOFI SoFi Technologies - SoFiUSD Stablecoin Is Significant Expansion of Digital Asset Business Summary: SOFI is one of the first movers into stablecoins among banks with a strong brand and multiple channels of distribution, providing a solid foundation to potentially become a

$INSP Inspire Medical Systems - Coal in the Stocking. Code Reversal (For Now) Causing Stock to Roundtrip